Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended April 2, 2004

 

Commission file Number 333-73160

 


 

ARMKEL, LLC

(Exact name of registrant as specified in its certificate of formation)

 


 

Organized in Delaware    
469 North Harrison Street    
Princeton, New Jersey 08543-5297   13-4181336
(Address of principal executive offices) (Zip Code)   I.R.S Employer Identification No.

 

(609) 683-5900

Registrant’s telephone Number, including area code

 


 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act: None

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act)    Yes  ¨    No  x

 

As of May 11, 2004, all of the 10,000 outstanding membership interests in Armkel, LLC were held by affiliates.

 


 


Table of Contents

TABLE OF CONTENTS

 

         PAGE

    PART I     

ITEM

        

1.

  Financial Statements    3

2.

  Management’s Discussion and Analysis    17

3.

  Quantitative and Qualitative Disclosure About Market Risk    21

4.

  Controls and Procedures    21
    PART II     

6.

  Exhibits and Reports on Form 8-K    22

 

2 of 23


Table of Contents

PART I - FINANCIAL INFORMATION

 

ITEM 1: FINANCIAL STATEMENTS

 

ARMKEL, LLC AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND

CHANGES IN MEMBERS’ EQUITY

(Unaudited)

 

     Three Months Ended

 

(Dollars in thousands)

 

   April 2,
2004


    March 28,
2003


 

Net Sales

   $ 113,773     $ 99,654  

Cost of goods sold

     48,088       41,169  
    


 


Gross Profit

     65,685       58,485  

Marketing expenses

     12,830       12,009  

Selling, general and administrative expenses

     23,044       21,376  
    


 


Income from Operations

     29,811       25,100  

Interest expense

     (7,765 )     (8,890 )

Interest income

     291       281  

Other expense

     (669 )     (284 )
    


 


Income before taxes

     21,668       16,207  

Income taxes

     3,505       3,104  
    


 


Income from continuing operations

     18,163       13,103  

Income from discontinued operations

     —         254  

Gain on disposition of discontinued operations

     —         1,862  
    


 


Net Income

     18,163       15,219  

Other comprehensive income

     4,833       648  
    


 


Total comprehensive income

     22,996       15,867  

Members’ Equity at Beginning of Period

     279,437       229,680  
    


 


Members’ Equity at End of Period

   $ 302,433     $ 245,547  
    


 


 

See Notes to Condensed Consolidated Financial Statements.

 

3 of 23


Table of Contents

ARMKEL, LLC AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(Dollars in thousands)    April 2, 2004

    Dec. 31, 2003

 
     (Unaudited)        

Assets

                

Current Assets

                

Cash and cash equivalents

   $ 64,757     $ 69,188  

Accounts receivable, less allowances of $1,558 and $1,509

     90,892       74,783  

Inventories

     55,619       53,782  

Prepaid expenses

     6,361       6,436  

Net assets held for sale

     11,500       11,500  
    


 


Total Current Assets

     229,129       215,689  

Property, Plant and Equipment (Net)

     76,153       75,815  

Tradenames and Patents

     255,650       256,775  

Goodwill

     205,156       205,156  

Deferred Financing Costs

     13,073       13,877  

Other Assets

     8,513       8,009  
    


 


Total Assets

   $ 787,674     $ 775,321  
    


 


Liabilities and Members’ Equity

                

Current Liabilities

                

Accounts payable and accrued expenses

   $ 86,916     $ 86,347  

Current portion of long-term debt

     3,029       2,705  

Taxes payable

     4,749       7,214  
    


 


Total Current Liabilities

     94,694       96,266  

Long-term Debt

     356,886       364,838  

Deferred Income Taxes

     8,165       9,669  

Deferred and Other Long-term Liabilities

     25,496       25,111  

Commitments and Contingencies

     —         —    
    


 


Total Liabilities

     485,241       495,884  

Members’ Equity

                

Net contributed capital

     220,500       220,500  

Retained earnings

     83,968       65,805  

Accumulated other comprehensive loss

     (2,035 )     (6,868 )
    


 


Total Members’ Equity

     302,433       279,437  
    


 


Total Liabilities and Members’ Equity

   $ 787,674     $ 775,321  
    


 


 

See Notes to Condensed Consolidated Financial Statements.

 

4 of 23


Table of Contents

ARMKEL, LLC AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

 

     Three Months Ended

 

(Dollars in thousands)

 

  

April 2,

2004


   

March 28,

2003


 
                  

Cash Flow From Operating Activities:

                

Net Income

   $ 18,163     $ 15,219  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation and amortization

     4,127       3,933  

Unrealized gain on foreign exchange transactions

     429       81  

Net (income) loss from discontinued operations

     —         (254 )

Net gain on sale of discontinued operations

     —         (1,862 )

Change in assets and liabilities:

                

Increase in accounts receivable

     (13,406 )     (12,337 )

Increase in inventories

     (613 )     (1,995 )

Decrease in prepaid expenses and other current assets

     146       326  

Decrease in accounts payable and other accrued expenses

     (3,865 )     (2,549 )

Decrease in other liabilities

     (2,221 )     (1,927 )
    


 


Net Cash Provided by (Used in) Operating Activities

     2,760       (1,365 )
    


 


Cash Flow From Investing Activities:

                

Additions to property, plant and equipment

     (1,938 )     (2,054 )

Proceeds from divestiture

     —         22,573  
    


 


Net Cash Provided by (Used in) Investing Activities

     (1,938 )     20,519  
    


 


Cash Flow From Financing Activities:

                

Repayment of syndicated bank credit facility

     (7,500 )     (26,253 )
    


 


Net Cash Used in Financing Activities

     (7,500 )     (26,253 )
    


 


Effect of exchange rate changes on cash and cash equivalents

     2,247       925  
    


 


Net Change in Cash and Cash Equivalents

     (4,431 )     (6,174 )

Cash and Cash Equivalents at Beginning of Period

     69,188       54,780  
    


 


Cash and Cash Equivalents at End of Period

   $ 64,757     $ 48,606  
    


 


 

See Notes to Condensed Consolidated Financial Statements.

 

 

5 of 23


Table of Contents

ARMKEL, LLC AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Financial Statement Presentation

 

The condensed consolidated balance sheet as of April 2, 2004, the condensed consolidated statements of income and changes in members’ equity for the three months ended April 2, 2004 and March 28, 2003, and the consolidated statements of cash flow for the three months ended April 2, 2004 and March 28, 2003 have been prepared by Armkel, LLC and subsidiaries (the “Company”) and are unaudited. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flow at April 2, 2004 and for all periods presented have been made.

 

Fifty-percent (50%) of the membership interests in the Company is owned by each of Church & Dwight Co., Inc. (“C&D”) and certain affiliates of Kelso & Company, L.P. (“Kelso”).

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2003 required Form 10-K filing. The financial statement effect of the Italian operations that were divested in February 2003 is recognized as discontinued operations. The results of operations for the period ended April 2, 2004 are not necessarily indicative of the operating results for the full year.

 

2. Inventories consist of the following (in thousands):

 

     April 2, 2004

   Dec. 31, 2003

Raw materials and supplies

   $ 12,319    $ 11,913

Work in process

     7,537      6,427

Finished goods

     35,763      35,442
    

  

     $ 55,619    $ 53,782
    

  

 

3. Property, Plant and Equipment consist of the following (in thousands):

 

     April 2, 2004

   Dec. 31, 2003

Land

   $ 7,198    $ 7,206

Buildings and improvements

     25,419      25,351

Machinery and equipment

     51,851      52,384

Office equipment and other assets

     6,430      5,999

Construction in progress

     3,516      816
    

  

       94,414      91,756

Less accumulated depreciation and amortization

     18,261      15,941
    

  

Net Property, Plant and Equipment

   $ 76,153    $ 75,815
    

  

 

4. Goodwill and Intangible Assets

 

The following tables discloses the carrying value of all intangible assets (in thousands):

 

     April 2, 2004

   December 31, 2003

     Gross Carrying
Amount


   Accum.
Amortization


   Net

   Gross Carrying
Amount


  

Accum.

Amortization


   Net

Amortized intangible assets:

                                         

Patents

   $ 27,500    $ 11,250    $ 16,250    $ 27,500    $ 10,125    $ 17,375
    

  

  

  

  

  

Unamortized intangible assets - Carrying value:

                                         

Tradenames

   $ 239,400                  $ 239,400              
    

                

             

 

 

6 of 23


Table of Contents

ARMKEL, LLC AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

 

Intangible amortization expense amounted to $1.1 million for the three months ended April 2, 2004 and March 28, 2003. The estimated intangible amortization is approximately $4.5 million per year over the remaining amortization period. The weighted average amortization period for patents is 6.4 years.

 

There were no changes in the carrying amount of goodwill for the three months ended April 2, 2004. The balances are as follows (in thousands):

 

     Domestic

   International

   Total

Balance April 2, 2004

   $ 172,318    $ 32,838    $ 205,156

 

5. Related Party Transactions

 

Arrangements with Church & Dwight

 

The Company owed C&D $6.6 million and $6.4 million for primarily administrative and management oversight services for the three months ended April 2, 2004 and March 28, 2003, respectively. The Company sold $0.5 million and $0.7 million of deodorant/antiperspirant inventory to C&D at its cost during the three months ended April 2, 2004 and March 28, 2003, respectively. The Company purchased $0.4 million and $0.8 million of Arm & Hammer products to be sold in international markets during the three months ended April 2, 2004 and March 28, 2003, respectively. The Company had a net payable to C&D at April 2, 2004 and March 28, 2003, respectively, of approximately $3.6 million and $3.5 million that primarily related to administration fees and invoices paid by C&D on behalf of Armkel, offset by amounts owed for inventory.

 

Arrangements with Kelso

 

Kelso provides the Company with financial advisory services for which the Company pays an annual fee of $1.0 million. The Company indemnifies Kelso against certain liabilities and reimburses expenses in connection with its engagement. For the three months ended April 2, 2004, the Company paid Kelso $0.3 million. The Company prepaid Kelso’s 2003 annual fee at the end of December 2002.

 

6. Commitments, Contingencies and Guarantees

 

a. On January 17, 2002, a petition for appraisal, Cede & Co., Inc. and GAMCO Investors, Inc. v. Medpointe Healthcare Inc., Civil